News articles about Albemarle (NYSE:ALB) have been trending somewhat negative recently, according to AlphaOne. The research firm, a subsidiary of Accern, scores the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. AlphaOne ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Albemarle earned a news sentiment score of -0.01 on AlphaOne’s scale. AlphaOne also assigned news headlines about the specialty chemicals company an impact score of 14 out of 100, indicating that recent news coverage is very unlikely to have an impact on the stock’s share price in the next few days.

Here are some of the headlines that may have impacted Alpha One’s rankings:

Shares of Albemarle (NYSE:ALB) opened at 105.52 on Friday. The stock has a market cap of $11.88 billion, a PE ratio of 18.56 and a beta of 1.41. The company’s 50-day moving average price is $104.69 and its 200-day moving average price is $92.26. Albemarle has a 52-week low of $65.57 and a 52-week high of $107.56.

Albemarle (NYSE:ALB) last issued its earnings results on Monday, February 27th. The specialty chemicals company reported $0.78 earnings per share for the quarter, topping the consensus estimate of $0.73 by $0.05. Albemarle had a return on equity of 14.38% and a net margin of 6.92%. The company had revenue of $696.70 million for the quarter, compared to analyst estimates of $642.68 million. During the same period in the prior year, the firm posted $1.03 EPS. The business’s revenue was down 3.6% compared to the same quarter last year. Analysts expect that Albemarle will post $4.18 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Monday, April 3rd. Stockholders of record on Wednesday, March 15th were paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 1.21%. The ex-dividend date of this dividend was Monday, March 13th. This is an increase from Albemarle’s previous quarterly dividend of $0.31. Albemarle’s dividend payout ratio is 63.54%.

Several equities analysts have commented on ALB shares. Robert W. Baird increased their price target on shares of Albemarle to $125.00 in a research note on Wednesday, March 1st. Jefferies Group LLC reiterated a “buy” rating and issued a $120.00 price target (up from $105.00) on shares of Albemarle in a research note on Wednesday, March 1st. Instinet increased their price target on shares of Albemarle from $102.00 to $118.00 and gave the company a “buy” rating in a research note on Wednesday, March 1st. Aegis started coverage on shares of Albemarle in a research note on Friday, February 17th. They issued a “buy” rating and a $108.00 price target on the stock. Finally, Zacks Investment Research upgraded shares of Albemarle from a “hold” rating to a “buy” rating and set a $119.00 price target on the stock in a research note on Tuesday, March 21st. Two analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Albemarle has a consensus rating of “Buy” and a consensus price target of $111.00.

COPYRIGHT VIOLATION NOTICE: This report was originally published by Financial Market News and is the sole property of of Financial Market News. If you are reading this report on another website, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The legal version of this report can be read at

Albemarle Company Profile

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

5 Day Chart for NYSE:ALB

Receive News & Ratings for Albemarle Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Co. and related companies with's FREE daily email newsletter.